Cargando…
Dose–response prediction for in-vitro drug combination datasets: a probabilistic approach
In this paper we propose PIICM, a probabilistic framework for dose–response prediction in high-throughput drug combination datasets. PIICM utilizes a permutation invariant version of the intrinsic co-regionalization model for multi-output Gaussian process regression, to predict dose–response surface...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10120211/ https://www.ncbi.nlm.nih.gov/pubmed/37085771 http://dx.doi.org/10.1186/s12859-023-05256-6 |
_version_ | 1785029147961065472 |
---|---|
author | Rønneberg, Leiv Kirk, Paul D. W. Zucknick, Manuela |
author_facet | Rønneberg, Leiv Kirk, Paul D. W. Zucknick, Manuela |
author_sort | Rønneberg, Leiv |
collection | PubMed |
description | In this paper we propose PIICM, a probabilistic framework for dose–response prediction in high-throughput drug combination datasets. PIICM utilizes a permutation invariant version of the intrinsic co-regionalization model for multi-output Gaussian process regression, to predict dose–response surfaces in untested drug combination experiments. Coupled with an observation model that incorporates experimental uncertainty, PIICM is able to learn from noisily observed cell-viability measurements in settings where the underlying dose–response experiments are of varying quality, utilize different experimental designs, and the resulting training dataset is sparsely observed. We show that the model can accurately predict dose–response in held out experiments, and the resulting function captures relevant features indicating synergistic interaction between drugs. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12859-023-05256-6. |
format | Online Article Text |
id | pubmed-10120211 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-101202112023-04-22 Dose–response prediction for in-vitro drug combination datasets: a probabilistic approach Rønneberg, Leiv Kirk, Paul D. W. Zucknick, Manuela BMC Bioinformatics Research In this paper we propose PIICM, a probabilistic framework for dose–response prediction in high-throughput drug combination datasets. PIICM utilizes a permutation invariant version of the intrinsic co-regionalization model for multi-output Gaussian process regression, to predict dose–response surfaces in untested drug combination experiments. Coupled with an observation model that incorporates experimental uncertainty, PIICM is able to learn from noisily observed cell-viability measurements in settings where the underlying dose–response experiments are of varying quality, utilize different experimental designs, and the resulting training dataset is sparsely observed. We show that the model can accurately predict dose–response in held out experiments, and the resulting function captures relevant features indicating synergistic interaction between drugs. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12859-023-05256-6. BioMed Central 2023-04-21 /pmc/articles/PMC10120211/ /pubmed/37085771 http://dx.doi.org/10.1186/s12859-023-05256-6 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Rønneberg, Leiv Kirk, Paul D. W. Zucknick, Manuela Dose–response prediction for in-vitro drug combination datasets: a probabilistic approach |
title | Dose–response prediction for in-vitro drug combination datasets: a probabilistic approach |
title_full | Dose–response prediction for in-vitro drug combination datasets: a probabilistic approach |
title_fullStr | Dose–response prediction for in-vitro drug combination datasets: a probabilistic approach |
title_full_unstemmed | Dose–response prediction for in-vitro drug combination datasets: a probabilistic approach |
title_short | Dose–response prediction for in-vitro drug combination datasets: a probabilistic approach |
title_sort | dose–response prediction for in-vitro drug combination datasets: a probabilistic approach |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10120211/ https://www.ncbi.nlm.nih.gov/pubmed/37085771 http://dx.doi.org/10.1186/s12859-023-05256-6 |
work_keys_str_mv | AT rønnebergleiv doseresponsepredictionforinvitrodrugcombinationdatasetsaprobabilisticapproach AT kirkpauldw doseresponsepredictionforinvitrodrugcombinationdatasetsaprobabilisticapproach AT zucknickmanuela doseresponsepredictionforinvitrodrugcombinationdatasetsaprobabilisticapproach |